drugset / Trial / NCT07534176

To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets .

NCT07534176 ↗

Phase 1 Recruiting 24 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

A Drug-Drug Interaction Study to Evaluate the Effect of Smoking (CYP1A2 Inducer) on the Pharmacokinetics Following a Single Oral Dose of GS1-144 Tablets in Chinese Healthy Postmenopausal Female Trial Participants

Timeline

Start
2026-05-20
Primary completion
2026-10-20
Completion
2027-02-08

Drugs

EvaluationDrugModalityDoseRoute
Subject GS1-144 Unknown 30 mg Oral

Indications

No indication recorded.